Faeth Therapeutics, Inc. (FTH)

Faeth Therapeutics, Inc. (FTH) is a healthcare company (biotechnology) based in the United States. The share price is $8.75, down 5.77% on the day, which values the company at $226.01M. Price as of 17 Nov 2026, 17:30 UTC, from Yahoo Finance.

Key facts

Share price
$8.75−5.77% today
Market value
$226.01M
200-week average
$17.2749% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Faeth Therapeutics, Inc. in more detail

FTH trades at -2.4× next year's expected earnings. It sits 49% below its 200-week average of $17.27.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Thin interest cover.

2 of the superinvestors tracked here hold FTH, including Julian and Felix Baker (0.2% of the portfolio), Peter Kolchinsky (0.2% of the portfolio).

Superinvestors holding FTH

2 of the investors tracked here report a position in their latest 13F filing.

Faeth Therapeutics, Inc. (FTH): questions and answers

What is Faeth Therapeutics, Inc.'s market cap?

Faeth Therapeutics, Inc. is valued at $226.01M at a share price of $8.75.

Is FTH above its 200-week moving average?

No. FTH is 49.3% below its 200-week average of $17.27. Long-term investors watch that line because strong companies rarely trade below it for long.

Does FTH pay a dividend?

Faeth Therapeutics, Inc. does not currently pay a regular dividend.

Which famous investors own FTH?

In their latest quarterly filings, Julian and Felix Baker (0.2% of the portfolio), Peter Kolchinsky (0.2% of the portfolio) hold FTH. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Faeth Therapeutics, Inc. (FTH) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/FTH

Underlying data: Yahoo Finance; company filings with the SEC.